Apellis Pharmaceuticals ROE - Return on Equity 2016-2024 | APLS
Apellis Pharmaceuticals roe - return on equity from 2016 to 2024. Roe - return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.